Pharming Group N.V. (PHAR) stock
PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.48+0.42 (+3.51%)
Close on Nov 18, 2026Market cap $875.92MP/E 312.1Yield –
Pharming net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was $2.85M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.85M | – |
| FY2024 | Dec 31, 2024 | -$11.84M | – |
| FY2023 | Dec 31, 2023 | -$10.55M | – |
See a number that looks wrong?